Pediatrix Medical Group's EBIT per Share for the
three
months ended in Mar. 2026 was MXN10.23.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was MXN56.44.
During the past 12 months, the average EBIT per Share Growth Rate of Pediatrix Medical Group was 19.40% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 4.50% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 2.10% per year.
During the past 10 years, the average EBIT per Share Growth Rate was -9.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Pediatrix Medical Group's EBIT per Share or its related term are showing as below:
MEX:MD'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -25 Med: 11.1 Max: 60.3
Current: 4.5
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Pediatrix Medical Group was 60.30% per year. The lowest was -25.00% per year. And the median was 11.10% per year.
MEX:MD's 3-Year EBIT Growth Rate is ranked worse than 62% of 529
companies
in the Healthcare Providers & Services industry
Industry Median: 11.8
vs MEX:MD: 4.50
Pediatrix Medical Group (MEX:MD) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Pediatrix Medical Group EBIT per Share Related Terms
Pediatrix Medical Group EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN56.44
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pediatrix Medical Group (MEX:MD) has a EBIT per Share of MXN56.44 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Pediatrix Medical Group and its competitors. According to the industry distribution chart, Pediatrix Medical Group ranks #328 out of 529 companies in the Healthcare Providers & Services industry, placing it in the top 62%.
Is Pediatrix Medical Group's EBIT per Share too high?
Pediatrix Medical Group's current EBIT per Share is MXN56.44. Based on the distribution chart, Pediatrix Medical Group ranks #328 out of 529 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Pediatrix Medical Group has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's EBIT per Share compare to SEM and AGL?
According to the Healthcare Providers & Services industry distribution chart, Pediatrix Medical Group ranks #328 out of 529 companies for EBIT per Share. This places Pediatrix Medical Group in the lower half of its industry. The industry median EBIT per Share is 11.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.80, based on 529 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Pediatrix Medical Group and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pediatrix Medical Group's current EBIT per Share is MXN56.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Pediatrix Medical Group (MEX:MD) has a current EBIT per Share of MXN56.44. The stock's GF Value™ is MXN162.36, compared to a current price of MXN323.00 — trading 98.9% above its estimated fair value. The current EBIT per Share is MXN56.44. Pediatrix Medical Group's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Pediatrix Medical Group (MEX:MD), the current EBIT per Share is MXN56.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pediatrix Medical Group (MEX:MD) Overvalued in 2026?
Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued.
The current stock price of MXN323.00 is trading 98.9% above its estimated GF Value™ of MXN162.36.
Key valuation signals for MEX:MD:
EBIT per Share: MXN56.44
GF Value™: MXN162.36 vs. price of MXN323.00 (98.9% above fair value)
No single metric tells the full story. See the MEX:MD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
59GF Score
Get the complete analysis for MEX:MD
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:MD has been successfully added to your 
